Recording session from the NCCN 2025 Hematological Malignancies Congress
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits
MOC types
ABPATH — Lifelong LearningUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 3025 Chemical Road
Pricing
CME included with membership
| Free CME Activity | Free |
| Paid Activity (e.g. Breast/Lung Cancer Congress recordings) | $50 |
| Paid Activity (e.g. Hematologic Malignancies Congress recording) | $90 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Anatomic & Clinical Pathology
- Colon & Rectal Surgery
- Communication & Shared Decision-Making
- Dermatopathology
- Evidence-Based Medicine & Research
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pain Medicine
- Pediatric Hematology-Oncology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Primary care
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Paid · this provider typically $50
- Commercial Support
-
ReleasedDec 1, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
Research to Practice Consensus or Controversy? Documenting and Discussing Investigators Approaches to the Management of Relapsed/Refractory Multiple Myeloma | 2026 (Symposium Proceedings)
-
Physicians’ Education Resource Module 7: Multiple Myeloma (MM): Relapsed/Refractory Disease
-
PVI, PeerView Institute for Medical Education On Track to Remission in Multiple Myeloma: Modern Management Choices in Relapsed/Refractory Disease
-
National Comprehensive Cancer Network Emerging Treatment Options for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
National Comprehensive Cancer Network Emerging Treatment Strategies for High-Risk Myelodysplastic Syndromes
-
National Comprehensive Cancer Network Recorded Presentation from the NCCN 2026 Annual Conference: Hematologic Malignancies
